Beam Therapeutics, Inc. (BEAM)
24.05
-0.51
(-2.08%)
USD |
NASDAQ |
Oct 23, 16:00
24.03
-0.02
(-0.08%)
After-Hours: 20:00
Beam Therapeutics Price to Book Value : 2.327 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 2.327 |
| October 22, 2026 | 2.376 |
| October 21, 2026 | 2.403 |
| October 20, 2026 | 2.412 |
| October 19, 2026 | 2.340 |
| October 16, 2026 | 2.270 |
| October 15, 2026 | 2.392 |
| October 14, 2026 | 2.288 |
| October 13, 2026 | 2.363 |
| October 12, 2026 | 2.431 |
| October 09, 2026 | 2.486 |
| October 08, 2026 | 2.380 |
| October 07, 2026 | 2.396 |
| October 06, 2026 | 2.441 |
| October 05, 2026 | 2.483 |
| October 02, 2026 | 2.370 |
| October 01, 2026 | 2.360 |
| September 30, 2026 | 2.365 |
| September 29, 2026 | 2.372 |
| September 28, 2026 | 2.344 |
| September 25, 2026 | 2.348 |
| September 24, 2026 | 2.386 |
| September 23, 2026 | 2.358 |
| September 22, 2026 | 2.508 |
| September 21, 2026 | 2.444 |
| Date | Value |
|---|---|
| September 18, 2026 | 2.414 |
| September 17, 2026 | 2.387 |
| September 16, 2026 | 2.235 |
| September 15, 2026 | 2.246 |
| September 14, 2026 | 2.333 |
| September 11, 2026 | 2.321 |
| September 10, 2026 | 2.358 |
| September 09, 2026 | 2.435 |
| September 08, 2026 | 2.596 |
| September 04, 2026 | 2.869 |
| September 03, 2026 | 2.85 |
| September 02, 2026 | 2.834 |
| September 01, 2026 | 2.807 |
| August 31, 2026 | 2.847 |
| August 28, 2026 | 2.836 |
| August 27, 2026 | 2.949 |
| August 26, 2026 | 2.921 |
| August 25, 2026 | 3.002 |
| August 24, 2026 | 2.741 |
| August 21, 2026 | 2.879 |
| August 20, 2026 | 2.746 |
| August 19, 2026 | 2.812 |
| August 18, 2026 | 2.570 |
| August 17, 2026 | 2.622 |
| August 14, 2026 | 2.588 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Intellia Therapeutics, Inc. | 2.157 |
| Twist Bioscience Corp. | 19.67 |
| Prime Medicine, Inc. | 16.66 |
| Sarepta Therapeutics, Inc. | 1.226 |
| Q32 Bio, Inc. | 1.939 |
Price to Book Value Related Metrics
| PS Ratio | 15.99 |
| Price | 24.05 |
| Earnings Yield | -3.58% |
| Market Cap | 2.484B |